KATHRYN GOSHORN: Open Payments
NPI 1952925612 · GOODYEAR, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$905 in 45 payments from 8 companies in 2025. Trend: 2023 $93 · 2024 $63 · 2025 $905
Food & beverage: $905
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 23 | $319 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $275 |
| Corium, LLC | 6 | $93 |
| ABBVIE INC. | 1 | $73 |
| Collegium Pharmaceutical, Inc. | 3 | $57 |
| Axsome Therapeutics, Inc. | 2 | $50 |
| Vertical Pharmaceuticals, LLC | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: Qelbree, CAPLYTA, Azstarys, VRAYLAR, Jornay PM, Auvelity, Relexxii, REXULTI.
Industry payments across AZ — which companies pay providers there.
